课题基金 / 基金详情

Placenta on a chip: A humanized platform for testing of pharmaceuticals and environmental chemicals

Placenta on a chip: A humanized platform for testing of pharmaceuticals and environmental chemicals
胎盘芯片:用于测试药物和环境化学品的人性化平台
批准号:
523792-2018
负责人:
Raha, Sandeep
金额:
$7.22万
依托单位:
依托单位国家:
加拿大
项目类别:
Collaborative Health Research Projects
财政年份:
2018
资助国家:
加拿大
项目状态:
已结题
起止时间:
2018-01-01 至 2019-12-31

项目摘要

项目成果

Raha, Sandeep的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The human placenta is a complex organ that controls the health of the baby and also impacts**the health of the mother. Signals from the cells that form the barrier between mother and fetus**can program the babies health after it is born or control whether the baby is born**prematurely. 1 in 9 babies are born prematurely and this can lead to many health problems in**later life. It is difficult to study this barrier in animal models or humans because of the**complexity of the placenta. Our research will develop a placenta on a chip; a micro-device**that mimics a small section of the human placenta in 3D. We will develop special surfaces**that allow the stem cells of the placenta to behave as though they were in their natural**environment within the womb. This portable placenta will be the first example of such a**device that brings together the important cells of the placenta and simulates the proper**oxygen levels and blood flow that would exist in the human placenta. This device will be very**useful in reducing the cost of testing drugs to see if they would be harmful to the mother or**fetus and also help to reduce the number of animals that are used in drug testing. Importantly,**we will also verify whether this device predicts the biological responses of actual placental**tissues when treated with environmental toxins; something that no one has evaluated. We will**easily and inexpensively be able to identify whether certain chemicals are causing the**maternal-fetal barrier to release signals that might harm the baby or cause premature birth.**We have already partnered with Evik Diagnostics, a Canadian company that is interested in**diagnostic testing for conditions that affect the health of the mother and baby in pregnancy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of endocannabinoids receptors in regulating trophoblast cell function
  • 批准号:
    RGPIN-2020-06739
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.04万
  • 财政年份:
    2022
  • 负责人:
    Raha, Sandeep
  • 依托单位:
The role of endocannabinoids receptors in regulating trophoblast cell function
  • 批准号:
    RGPIN-2020-06739
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.04万
  • 财政年份:
    2021
  • 负责人:
    Raha, Sandeep
  • 依托单位:
The role of endocannabinoids receptors in regulating trophoblast cell function
  • 批准号:
    RGPIN-2020-06739
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.04万
  • 财政年份:
    2020
  • 负责人:
    Raha, Sandeep
  • 依托单位:
Placenta on a chip: A humanized platform for testing of pharmaceuticals and environmental chemicals
  • 批准号:
    523792-2018
  • 项目类别:
    Collaborative Health Research Projects
  • 资助金额:
    $14.18万
  • 财政年份:
    2019
  • 负责人:
    Raha, Sandeep
  • 依托单位:
国内基金
海外基金
CHIP泛素化修饰CIB1结合PLK2介导线粒体功能障碍重塑肺腺癌糖代谢调 控肿瘤细胞转移
  • 批准号:
    2026JJ50309
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    周燕武
  • 依托单位:
CHIP通过泛素化修饰RIP3调控巨噬细胞 坏死性凋亡在角膜新生血管形成中的作 用
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    叶一明
  • 依托单位:
TAT-CHIP 融合蛋白减轻脓毒症心功能障碍的作用及机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    30.0万元
  • 批准年份:
    2024
  • 负责人:
    吴森泉
  • 依托单位:
Triptonide 通过 CHIP 介导的蛋白酶体途径清 除野生型IDH1 急性髓系白血病细胞的机制 研究
  • 批准号:
    TGY24H080029
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    杨琳琳
  • 依托单位: